Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Medicinal Research Reviews
|
August 19, 2020
Cerebrolysin in the therapy of mild cognitive impairment and dementia due to Alzheimer's disease: 30 years of clinical use
Svetlana I Gavrilova, Anton Alvarez
Medicinal Research Reviews
|
April 13, 2023
Modulation of neurotrophic factors in the treatment of dementia, stroke and TBI: Effects of Cerebrolysin
Konrad Rejdak, Halina Sienkiewicz-Jarosz, Przemyslaw Bienkowski, et al.
International Clinical Psychopharmacology
|
February 25, 2005
Effects of N-PEP-12 on memory among older adults
Thomas H Crook, Steven H Ferris, X Anton Alvarez, et al.
Frontiers in Psychology
|
October 29, 2020
Neuromarketing Highlights in How Asperger Syndrome Youth Perceive Advertising
Patricia Nuñez-Gomez, Anton Alvarez-Ruiz, Felix Ortega-Mohedano, et al.
Environmental Science & Technology
|
December 21, 2016
Development and Application of a Life Cycle-Based Model to Evaluate Greenhouse Gas Emissions of Oil Sands Upgrading Technologies
Diana M Pacheco, Joule A Bergerson, Anton Alvarez-Majmutov, et al.
Journal of Alzheimer'S Disease : JAD
|
May 2, 2018
Severity-Related Increase and Cognitive Correlates of Serum VEGF Levels in Alzheimer's Disease ApoE4 Carriers
X Anton Alvarez, Irene Alvarez, Manuel Aleixandre, et al.
The International Journal of Neuropsychopharmacology
|
June 18, 2009
Reduced TNF-α and increased IGF-I levels in the serum of Alzheimer's disease patients treated with the neurotrophic agent cerebrolysin
X Anton Alvarez, Carolina Sampedro, Ramon Cacabelos, et al.
Journal of the Neurological Sciences
|
December 1, 2007
A pilot study to evaluate the effects of Cerebrolysin on cognition and qEEG in vascular dementia: cognitive improvement correlates with qEEG acceleration
Dafin F Muresanu, X Anton Alvarez, Herbert Moessler, et al.
Journal of the Neurological Sciences
|
October 7, 2010
Persistence of the effects of Cerebrolysin on cognition and qEEG slowing in vascular dementia patients: results of a 3-month extension study
Dafin F Muresanu, X Anton Alvarez, Herbert Moessler, et al.
Journal of Neuroscience Research
|
July 28, 2011
Beneficial effects of a neurotrophic peptidergic mixture persist for a prolonged period following treatment interruption in a transgenic model of Alzheimer's disease
Edward Rockenstein, Kiren Ubhi, Emiley Pham, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Medicinal Research Reviews
|
August 19, 2020
Cerebrolysin in the therapy of mild cognitive impairment and dementia due to Alzheimer's disease: 30 years of clinical use
Svetlana I Gavrilova, Anton Alvarez
Medicinal Research Reviews
|
April 13, 2023
Modulation of neurotrophic factors in the treatment of dementia, stroke and TBI: Effects of Cerebrolysin
Konrad Rejdak, Halina Sienkiewicz-Jarosz, Przemyslaw Bienkowski, et al.
International Clinical Psychopharmacology
|
February 25, 2005
Effects of N-PEP-12 on memory among older adults
Thomas H Crook, Steven H Ferris, X Anton Alvarez, et al.
Frontiers in Psychology
|
October 29, 2020
Neuromarketing Highlights in How Asperger Syndrome Youth Perceive Advertising
Patricia Nuñez-Gomez, Anton Alvarez-Ruiz, Felix Ortega-Mohedano, et al.
Environmental Science & Technology
|
December 21, 2016
Development and Application of a Life Cycle-Based Model to Evaluate Greenhouse Gas Emissions of Oil Sands Upgrading Technologies
Diana M Pacheco, Joule A Bergerson, Anton Alvarez-Majmutov, et al.
Journal of Alzheimer'S Disease : JAD
|
May 2, 2018
Severity-Related Increase and Cognitive Correlates of Serum VEGF Levels in Alzheimer's Disease ApoE4 Carriers
X Anton Alvarez, Irene Alvarez, Manuel Aleixandre, et al.
The International Journal of Neuropsychopharmacology
|
June 18, 2009
Reduced TNF-α and increased IGF-I levels in the serum of Alzheimer's disease patients treated with the neurotrophic agent cerebrolysin
X Anton Alvarez, Carolina Sampedro, Ramon Cacabelos, et al.
Journal of the Neurological Sciences
|
December 1, 2007
A pilot study to evaluate the effects of Cerebrolysin on cognition and qEEG in vascular dementia: cognitive improvement correlates with qEEG acceleration
Dafin F Muresanu, X Anton Alvarez, Herbert Moessler, et al.
Journal of the Neurological Sciences
|
October 7, 2010
Persistence of the effects of Cerebrolysin on cognition and qEEG slowing in vascular dementia patients: results of a 3-month extension study
Dafin F Muresanu, X Anton Alvarez, Herbert Moessler, et al.
Journal of Neuroscience Research
|
July 28, 2011
Beneficial effects of a neurotrophic peptidergic mixture persist for a prolonged period following treatment interruption in a transgenic model of Alzheimer's disease
Edward Rockenstein, Kiren Ubhi, Emiley Pham, et al.
Page
of 2